Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor...

17
Overdose Prevention & Naloxone Policy and Procedures Effective date: I. PURPOSE The purpose of this policy is to provide approved staff with guidelines to utilize naloxone in order to reduce fatal opioid overdose while engaging clients in the treatment setting. II. POLICY It is the policy of (Your agency) for trained staff to administer naloxone, in accordance with state law and the administrative medical director’s guidelines and oversight, to persons suffering from opioid overdose at the earliest possible opportunity to minimize chance of death. III. DEFINITIONS A. EMS: Emergency Medical Services that provide pre-hospital emergency medical care; such practitioners provide out of hospital care for those with an illness or injury B. Naloxone: An opioid antagonist and antidote for opioid overdose produced in intramuscular and intranasal forms C. Opioids: Catchall term for prescription, synthetic, semi-synthetic, or natural opiate drugs D. Opiates: Naturally derived drugs from the poppy plant, such as heroin or opium E. Opioid Overdose: An acute condition caused by the flooding of the opioid receptors in the brain by opioids. It can cause extreme physical illness, decreased level of consciousness, respiratory arrest, or death. F. IM Naloxone: Refers to the intramuscular (IM) administration of naloxone, either from a vial and syringe (manufactured by Hospira) or an auto-injector (manufactured by Kaleo, branded Evzio) G. IN Naloxone: Refers to the intranasal (IN) administration of naloxone, either from a nasal spray device (manufactured by Adapt, branded Narcan) or a 2mg/2ml syringe with nasal adaptor (manufactured by IMS/Amphastar)

Transcript of Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor...

Page 1: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

Overdose Prevention & Naloxone Policy and Procedures Effective date:

I. PURPOSEThepurposeofthispolicyistoprovideapprovedstaffwithguidelinestoutilizenaloxoneinordertoreducefatalopioidoverdosewhileengagingclientsinthetreatmentsetting.

II. POLICYItisthepolicyof(Youragency)fortrainedstafftoadministernaloxone,inaccordancewithstatelawandtheadministrativemedicaldirector’sguidelinesandoversight,topersonssufferingfromopioidoverdoseattheearliestpossibleopportunitytominimizechanceofdeath.

III. DEFINITIONSA. EMS:EmergencyMedicalServicesthatprovidepre-hospitalemergencymedicalcare;suchpractitionersprovideoutofhospitalcareforthosewithanillnessorinjuryB. Naloxone:AnopioidantagonistandantidoteforopioidoverdoseproducedinintramuscularandintranasalformsC. Opioids:Catchalltermforprescription,synthetic,semi-synthetic,ornaturalopiatedrugsD. Opiates:Naturallyderiveddrugsfromthepoppyplant,suchasheroinoropiumE. OpioidOverdose:Anacuteconditioncausedbythefloodingoftheopioidreceptorsinthebrainbyopioids.Itcancauseextremephysicalillness,decreasedlevelofconsciousness,respiratoryarrest,ordeath.F. IMNaloxone:Referstotheintramuscular(IM)administrationofnaloxone,eitherfromavialandsyringe(manufacturedbyHospira)oranauto-injector(manufacturedbyKaleo,brandedEvzio)G. INNaloxone:Referstotheintranasal(IN)administrationofnaloxone,eitherfromanasalspraydevice(manufacturedbyAdapt,brandedNarcan)ora2mg/2mlsyringewithnasaladaptor(manufacturedbyIMS/Amphastar)

Page 2: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

IV. ON-SITENALOXONEUSEPROCEDURES

A. (Youragency)shallappointaNaloxoneCoordinator.TheNaloxoneCoordinator’sresponsibilitieswillinclude:

1. Workingwithadministrativemedicaldirectortocreateanagency-widestandingorderfornaloxone(seeAppendix1fortemplate)2. Collaboratingwithlocalpartnerstoobtainnaloxone,eitherdirectlyorbyprescription3. Choosekeyareastostorenaloxone,ensuringthatstoragetemperaturesdonotexceedrecommendedrange4. Ensurethatnaloxonekitsarecurrentandnotpastexpirationdate5. Ensurethatauthorizedstaffareadequatelytrainedinoverdoserecognition,naloxoneuse,andstorage(seesubsectionsIV.D.andIV.E.)6. Createandmaintainnaloxoneusereportformandlog(seeAppendix2fortemplate)7. Replacenaloxonekitsthataredamaged,unusable,expired,orused.

B. EachIM(intramuscular)naloxonekitshallinclude:

1. Instructionsforadministrationofnaloxone(seeAppendix3forexample);2. TwoIMsyringes(preferably22-25g,1-1.5”,3cc)and3. Twovials0.4mg/mLnaloxonebyHospira;OR4. OneboxEvzioauto-injectorbyKaleo(comeswithtwodevices);5. OneCPRfacemask/barrierdeviceformouth-to-mouthresuscitation

C. EachIN(intranasal)naloxonekitshallinclude:1. Instructionsforadministrationofnaloxone(seeAppendix4forexample);2. OneboxNarcannasalspraybyAdapt(comeswithtwodevices);OR3. Twovials2mg/2mLnaloxonebyAmphastarand4. Two2mLLuer-JetLuer-Lockneedlelesssyringeand5. Twomucosalatomizerdevices(MAD-300);6. OneCPRfacemask/barrierdeviceformouth-to-mouthresuscitation

Page 3: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

D. IndicationsandUse1. Authorizedstaffshallcheckforresponsivenessifclientisbelievedtobesufferingfromanopioidoverdose.Informationthataclientissufferingfromanopioidoverdoseincludes,butisnotlimitedto:

• Noresponsetoexternalstimulation,suchasasternumrub• Blueorgrayskin,lips,orfingertips• Depressedorslowrespirations• Difficultybreathing(labored,shallow,orhaltedbreaths)• Decreasedpulserate• Pinpointpupils,eveninadarkenedenvironment• Evidenceofingestion,inhalation,orinjection(needles,cookers,

tourniquets,needletracks,aluminumfoil,etc.)2. StaffshallsummonEMSbycalling911andcommunicatingthatthepatientisnotbreathingorinsuspectedoverdose,andthatnaloxoneadministrationisintended3. StaffshallmaintainuniversalprecautionsagainstpathogensbyusinglatexglovesifusingIMnaloxone,andusingaCPRfaceshieldorbarrierifperformingrescuebreathing.4. Staffshalladministeronedoseofnaloxone5. Ifpossible,staffshallbeginrescuebreathingfortwominutes.Rescuebreathingconsistsofonedeepbreathinthesubject’smoutheveryfiveseconds,ensuringthatclientislyingontheirback,headistiltedup,andnoseisplugged.6. Ifnoresponseaftertwominutes,staffshalladministerseconddoseofnaloxoneandresumerescuebreathinguntilclientbeginsbreathingontheirownorEMSarrives7. StaffshallensureaccuratecommunicationtoEMSforproperpatientrecorddocumentationbeforetransporttohospitalemergencydepartment8. Supervisornotificationshouldbemadeassoonaspracticable9. Documentationofnaloxoneuseshouldberecorded.

Page 4: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

E. Maintenance,Storage,andReplacementofNaloxone1. StaffwhousenaloxoneshallcommunicatewithNaloxoneCoordinatortoensurenaloxoneisreplaced2. Missing,damaged,orexpirednaloxonekitswillbereporteddirectlytotheNaloxoneCoordinatorandreplaced3. Temperaturestorage:

• IMHospirakitsstoreat68-77°F• IMEvziostoreat59-77°F,incursionspermittedfrom39-104°F• INNarcanspraystoreat59-77°F,incursionspermittedfrom39-104°F• INAmphastarkitsstoreat59-86°F

V. DISTRIBUTING/PRESCRIBINGNALOXONETOCLIENTSA. Identifyingclientswhomaybenefitfromoverdoseprevention/naloxonetraining:

1. Clientswithopioidusedisorderdiagnosis;2. Clientswithhistoryofopioiduse,abuse,ordependence;3. Currentopioidusers;4. Pastopioiduseandrecentreleasefromjail,prison,detox,inpatient,hospital,orafteranyperiodofsustainedabstinence;5. Friendsorfamilymembersofanyoftheabove.

B. Educatingclientsonintake,assessment,orbeforerelease

1. Identifyclientinneedofoverdoseprevention/naloxonetraining2. Askclientiftheyhavewitnessedorexperiencedanoverdose,andwhattheyknowaboutoverdoseprevention3. Reviewthe5componentsofoverdoserisk:

• Mixingdrugs• Tolerancechanges• Quality/purity• Physicalhealth• Usingalone

4. Teachclienthowtorecognizeanoverdose:• Noresponsetoexternalstimulation,suchasasternumrub• Blueorgrayskin,lips,orfingertips• Depressedorslowrespirations• Difficultybreathing(labored,shallow,orhaltedbreaths)• Decreasedpulserate• Pinpointpupils,eveninadarkenedenvironment

Page 5: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

• Evidenceofingestion,inhalation,orinjection(needles,cookers,tourniquets,needletracks,aluminumfoil,etc.)

5. Educateclientonnaloxoneinformation:• Onlyworksonopioids,maynotworkonpoly-drugOD• Wearsoffafter45-90minutes,overdosemayreoccur• Patientwillbesickandmaywanttouseagain• Naloxonecannothurtaperson

6. Educateclientonnaloxoneuse• Checkforresponsivenesswithsternumrub• Call911• Administer1doseofnaloxone• Rescuebreathefortwominutes• Ifnoresponse,administer2nddoseofnaloxone• Continuetorescuebreatheuntilparamedicsarrive

7. Encourageclienttoreportanyuseofnaloxoneforoverdosereversalandtoobtainarefillifused,lost,expired,stolen,ordestroyed8. Obtainsigneddocumentfromclientstatingthatstafftrainedthemonoverdoseprevention,recognition,andresponse(seeAppendix5)

C. PrescribeorDispenseNaloxone

1. Toprescribe:PrescriptionmaybewrittentoclientbyanMD,NP,PA,orDO2. Staffwillobtainprescribednaloxoneforclient,eitherdirectlyatthepharmacyorfromadeliveringpharmacyandensurethatclientreceivesthemedicationassoonaspossible3. AHCCCScoversallformulationsexceptforEvzioautoinjector;mostotherprivateinsurancescovernaloxoneaswell4. Todispense:Naloxonemaybeobtainedthroughseveralavenues:

• Staffcanpurchasenaloxoneforclientfromapharmacistwithoutaprescription.NotethatasofJanuary2017,insuranceswillnotcoverover-the-counternaloxone

• Agencycancollaboratewithothercommunitypartnerstoreceivenaloxonekitsfordistributiontoclientswithbarrierstoobtainingprescriptionsorprescribedmedication

• AsofJanuary2017,agenciescanapplyfordonatedproductfromClintonFoundation(forAdaptNarcannasalspray)orKaleo(forEvzioautoinjector)

Page 6: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

5. Ifdispensingwithoutaprescription,agencymustuseastandingorder(seeAppendix1)

VI. TrackingNaloxoneDistributionandReversalReportsRecordingnaloxoneprescription,distribution,andorreversalreportsshowsuccessoftheprogramandisveryimportantkeepalogwithinformation,includingbutnotlimitedto:A. Clientname(OPTIONAL!)B. Engagement/trainingdateC. Typeofnaloxonegiven(IMorIN)D. DateprescriptionwaswrittenE. DateprescriptionwasfilledornaloxonedispensedF. Dateofreporteduseforreversal

InformationshouldbetrackedandloggedbyNaloxoneCoordinator.Ifpartneringwithanoutsideagencytoobtainnaloxone,reportinformationtothatagency.

Page 7: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

Appendix1Standingordertemplate

Page 8: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

OverdoseEducationandNaloxoneDistributionProject

NALOXONESTANDINGORDER

Naloxoneisindicatedforthereversalofopioidoverdoseinducedbynaturalorsyntheticopioidsinthesettingofrespiratorydepressionorunresponsiveness.Itiscontraindicatedinpatientsknowntobehypersensitivetonaloxonehydrochloride.

Thisstandingordercoversthepossessionanddistributionofnaloxonekits,toincludenaloxonehydrochloride,intramuscularsyringes,andoverdosepreventionmaterials,inconjunctionwiththeSPWOverdoseEducationandNaloxoneDistributionProject.

1. ThisstandingorderauthorizesalltrainedstaffandvolunteersattheAGENCY NAMEtomaintainsuppliesofnaloxonekitsforthepurposeofusingthemtorescueaparticipantthoughttobeoverdosingonopioids;anddistributingthemtoapersonatriskofexperiencinganopioid-relatedoverdoseortoafamilymember,friend,orotherpersoninapositiontoassistanindividualatriskofexperiencinganopioid-relatedoverdose.

OrdertoDispenseUponsatisfactoryassessmentthatthepersontoreceivethenaloxonekitisapersonatriskofexperiencinganopioid-relatedoverdoseorafamilymember,friend,orotherpersoninapositiontoassistapersonatriskofexperiencinganopioid-relatedoverdose,anduponcompletionoftrainingregardingrecognizingandrespondingtosuspectedopioidoverdose,dispenseonenaloxonekit,toincludeataminimum:

§ Two1mlvialsofnaloxonehydrochloride§ Twointramuscularsyringes§ Printedmaterialstoincludehowtorecognizeandrespondtosuspectedopioidoverdose,

howtousethedevice,howtodisposeofsyringes,andtheimportanceofsummoningemergencyresponders

Theauthorizeddispenserwilllogalldispensednaloxoneandoverdoserescuesonaformapprovedbytheorderingphysician.

DirectionsforAdministrationAdministernaloxonetoapersonsuspectedofanopioidoverdosewithrespiratorydepressionorunresponsivenessasfollows:

1. Ifpractical,summonemergencymedicalservices2. Removelidfromnaloxonevial3. Insertsyringeintovialanddrawup1mlofnaloxone4. Administer1mlofnaloxoneviaintramuscularinjectionintoupperarm,buttock,orthigh5. Initiaterescuebreathingandmonitorrespirationandresponsivenessofnaloxone

recipient

Page 9: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

6. Ifnoresponseafter2-3minutes,administeranother1mldoseofnaloxoneviaintramuscularinjection

_______________________________________ _____________________Physician’sSignatureandLicenseNo. Date

_______________________________________ __________________PhysiciansName(print) OrderExpiration

Page 10: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

Appendix2Naloxonedistribution&usetrackinglog

Page 11: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

OverdoseEducation&NaloxoneDistributionTracking

Distributionsite:Clientname:

Trainername:

#&typeofkitsprescribed:

Dateprescriptionwritten:

Dateclientobtainednaloxone:

Dateofreporteduse:

Locationofreporteduse:

Naloxoneusedbywhom:

Page 12: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

Appendix3Intramuscularnaloxoneinstructions

Page 13: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

Ifyoususpectanopiateoverdose,rubtheperson’ssternumhardwithyourknuckles.Iftheydonotrespondtothepain,call911,&thengivethepersonnaloxone.

1. Poptheorangelidoffofonevial.Stickanintramuscular1”needleintothethinfilm&pullupalloftheliquid.Ifyoudon’thaveanintramuscularneedle,youcanuseaninsulinsyringe,thoughitisnotideal.

2. Stickthatbadboyinyourfriend’sarmorthighandinjectallofthemedication.Noneedtolookforavein.

3. Whileyou’rewaitingforittokickin,performrescuebreathingontheperson.Noneedforchestcompressions,justtilttheirheadback,plugtheirnose,andgiveadeepbreathevery5seconds.

4. Ifthefirstdosedoesn’twakeyourfriendupwithin2minutes,givethemtheseconddose.Useanewsyringe.5. Continuetorescuebreatheforthemuntiltheycanbreatheontheirown.6. Oncethey’rebreathingontheirown,placethemontheirsidewiththeirhandundertheirhead.

Importantinfotoknow:

• Evenwithnaloxone,yourfriendmaystillbeatriskofdeathiftheyhavetakenamixtureofbenzos(Xanax,Valium,etc.)oralcoholwiththeopiates,oriftheiropiateswerecutwithfentanylorotherlong-actingopioids.

• Yourfriendwillfeelverysickwhentheywakeup,asnaloxonebringsonimmediatewithdrawal.DONOTLETTHEMUSE,eventhoughtheymaywantto.Otherwisetheymayoverdoseagain.Theymaybeatriskofoverdosingagain1-3hoursafterthenaloxonewearsoffeveniftheydon’tuse,sogetthemmedicalattention.

• Whencalling911:Allyouneedtosayisthatyourfriendisnotbreathing.Ifthedispatcheraskswhy,youarenotobligatedtostateitisanoverdose.Thiswillincreasethelikelihoodthatonlytheparamedicsshowup,notthepolice.Generally,theparamedicsjustwanttohelptheperson&leave,somakesureyoutellthemeverythingyouknowwhentheygetthere.

Whatputsyouatriskofanoverdose?

Overdosehappenswhentheopiatereceptorsinyourbraingetsofilledwithopiates,thatyourbreathingslowstothepointofrespiratoryfailure.Whenyoustopbreathing,yourbrainstopsfunctioning,leadingtodeath.

Thisusuallyhappenswhenyoutakemoreopiatesthanyourbodycanhandle.

Thisoccurswhen:

• Yourtoleranceislowered,duetorecentlygettingoutofdetox,treatment,orjail• Youareusingdope/pillsthatarestrongerthanyouareusedto,i.e.newcut,newdealer,highermg• Yourimmunesystemisweakenedbecauseyouaresickorrecentlygotoverbeingsick• Yourecentlystartedinjecting,orregularlyswitchbetweensmoking/snorting&injecting• Youaremixingopiateswithbenzos(Xanax/Valium,etc)oralcohol–thisisverydangerous!!

Waystoavoidoverdosing:

• Ifyouhaveanewsource,oryouhavebeenusinglessornotatall,testitout!!Youcanalwaysdomore–butyoucan’tdoless.

• Considersmokingorsnortinginsteadofinjectingsoyouknowhowstrongitis.• Trynottousealone.Thisway,ifyoufallout,therewillbepeoplearoundtowitnessit.• Ifyouareusingalone,letpeopleinthehouseknow,ifyoucan,&don’tlockthedoor.

Page 14: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

Appendix4Intranasalkitinstructions

Page 15: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

Ifyoususpectanopiateoverdose,rubtheperson’ssternumhardwithyourknuckles.Iftheydonotrespondtothepain,call911,&thengivethepersonnaloxone.

1. Layyourfriendontheirback.2. PeelthesilverbackingoffoftheNarcanpackage.3. DONOTtestthedevice.Onceyoupushtheplunger,itallcomesoutatonceandyouwill

notbeabletosprayanymore.4. Stickthetipofthedeviceintoyourfriend’snostrilandpushtheplunger,expellingallof

themedication.5. Whileyou’rewaitingforittokickin,performrescuebreathingontheperson.Noneed

forchestcompressions,justtilttheirheadback,plugtheirnose,andgiveadeepbreathevery5seconds.

6. Ifthefirstdosedoesn’twakeyourfriendupwithin2minutes,givethemtheseconddose.Useanewsyringe.7. Rescuebreatheforthemuntiltheycanbreatheontheirown.8. Oncethey’rebreathingontheirown,placethemontheirsidewiththeirhandundertheirhead.

Importantinfotoknow:

• Evenwithnaloxone,yourfriendmaystillbeatriskofdeathiftheyhavetakenamixtureofbenzos(Xanax,Valium,etc.)oralcoholwiththeopiates,oriftheiropiateswerecutwithfentanylorotherlong-actingopioids.

• Yourfriendwillfeelverysickwhentheywakeup,asnaloxonebringsonimmediatewithdrawal.DONOTLETTHEMUSE,eventhoughtheymaywantto.Otherwisetheymayoverdoseagain.Theymaybeatriskofoverdosingagain1-3hoursafterthenaloxonewearsoffeveniftheydon’tuse,sogetthemmedicalattention.

• Whencalling911:Allyouneedtosayisthatyourfriendisnotbreathing.Ifthedispatcheraskswhy,youarenotobligatedtostateitisanoverdose.Thiswillincreasethelikelihoodthatonlytheparamedicsshowup,notthepolice.Generally,theparamedicsjustwanttohelptheperson&leave,somakesureyoutellthemeverythingyouknowwhentheygetthere.

Whatputsyouatriskofanoverdose?

Overdosehappenswhentheopiatereceptorsinyourbraingetsofilledwithopiates,thatyourbreathingslowstothepointofrespiratoryfailure.Whenyoustopbreathing,yourbrainstopsfunctioning,leadingtodeath.

Thisusuallyhappenswhenyoutakemoreopiatesthanyourbodycanhandle.

Thisoccurswhen:

• Yourtoleranceislowered,duetorecentlygettingoutofdetox,treatment,orjail• Youareusingdope/pillsthatarestrongerthanyouareusedto,i.e.newcut,newdealer,highermg• Yourimmunesystemisweakenedbecauseyouaresickorrecentlygotoverbeingsick• Yourecentlystartedinjecting,orregularlyswitchbetweensmoking/snorting&injecting• Youaremixingopiateswithbenzos(Xanax/Valium,etc)oralcohol–thisisverydangerous!!

Waystoavoidoverdosing:

• Ifyouhaveanewsource,oryouhavebeenusinglessornotatall,testitout!!Youcanalwaysdomore–butyoucan’tdoless.

• Considersmokingorsnortinginsteadofinjectingsoyouknowhowstrongitis.• Trynottousealone.Thisway,ifyoufallout,therewillbepeoplearoundtowitnessit.• Ifyouareusingalone,letpeopleinthehouseknow,ifyoucan,&don’tlockthedoor.

Page 16: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

Appendix5Signedproofofnaloxonetraining

Page 17: Overdose Prevention & Naloxone Policy and Procedures€¦ · syringe with nasal adaptor (manufactured by IMS/Amphastar) IV. ON-SITE NALOXONE USE PROCEDURES A. (Your agency) shall

NaloxoneDistributionTrainingChecklistTrainer Initials

The most common drugs identified in an opioid-related death (heroin, oxycodone, hydrocodone, fentanyl) and the physical effects these drugs have (slow, shallow, irregular breathing; low pulse; euphoria; unconsciousness) The main causes of drug overdose (low tolerance, polydrug use, using too much, using alone, injecting drug use, purity levels, adulterants like fentanyl) High-risk times (release from prison/jail, leaving rehab or hospital, recent detox, recent relapse, poor physical or mental health, new source, recent significant life events, cash windfall) The signs & symptoms of suspected opiate overdose (slowed/irregular breathing, blue/gray skin/lip color, no response to noise or touch, loss of consciousness) The common myths (Don’t: inflict pain, “balance out” with other drugs, put in bath/shower, ice down the pants, sleep it off) Knows how and when to call 911 (“Person is not breathing” rather than reporting overdose to dispatcher; call 911 before administering naloxone)

Knows when and how to administer naloxone (After non-responsiveness to stimuli. Second dose if not responsive after 2 minutes. Review different naloxone devices.)

Knows about rescue breathing (Clear airway. Pinch the person’s nose, tilt head back, and give deep breaths every five seconds. No need for chest compressions.) Knows about the recovery position (person on side, airway open)

Knows that naloxone is short acting (the effects of naloxone wear off after 45-90 mins, possible that overdose may return) Knows the importance of staying with the person (do not let the person use any other drugs if they gain consciousness, monitor for relapse into respiratory arrest) Knows the importance of not re using the product or the needle once the pack has been opened and how to dispose of used syringe if intramuscular naloxone was used. Knows that developing a plan is important (raising awareness about Naloxone access and OD prevention) Has been informed where to receive naloxone (doctor, community organizations, pharmacies)

Review: I verify I have received the training outlined above: Printed Name______________

1. Check for responsiveness Signature:_______________ 2. Call 911 Date: __________________ 3. Give 1st dose of Naloxone4. Rescue breathe for 2 minutes5. Give them a 2nd dose, if no response6. If you must leave, put them in the recovery position7. Transfer care to EMT or Emergency Department8. Monitor to make sure they do not overdose again